$10.026
0.000 (0.00%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TMTS Prediction & Forecast by Similar Chart Analysis
Alphio's TMTS stock price prediction model matches the current Spartacus Acquisition Corp II tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.17 (+1.40%). The 1-week path is $10.10 (+0.74%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Spartacus Acquisition Corp II Stock?
Currently, TMTS is trading at $10.03, which is near the 52-week low of $9.90, but the RSI is at 80.328, indicating it is overbought. The forward P/E ratio is 0, suggesting no expected earnings growth, which is a concern. The stock has shown a slight increase of 1.07% year-to-date, but the lack of significant trading trends from insiders and hedge funds indicates uncertainty. Given these factors, it may be prudent to hold rather than buy at this time.
TMTS stock price ended at $10.03 on Wednesday, after rising 0.00%
Spartacus Acquisition Corp II (TMTS) last closed at $10.0263996, gaining +0.00%. These facts feed the 1-day and 1-week TMTS price prediction above.
Forecast Drivers
Spartacus Acquisition Corp II (TMTS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches TMTS, ranked by similarity.
Seasonality analysis for TMTS
Related articles
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
- AppLovin Q3 2026 Deep Dive: Beaten-Down S&P Dog Meets Axon Next-Gen Beat-and-Raise—and a $3.2B BuybaAppLovin Q3 2026: $2.185B rev (+55%), EPS $4.30 vs ~$4.03–4.04 Street, Adj EBITDA $1.842B (84%). Beat own guide $100M; Q4 $2.365–2.395B; auth +$3.2B; AH +22–24%.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.